Table 2.

Psoriasis area severity index (PASI) and comorbidities in patients receiving etanercept treatment for psoriasis, stratified by weight (n = 66).

Parameter	Weight <80 kg	Weight ≥80 kg
	n = 34	n = 32
PASI
Before treatment	12.19 ± 6.00	16.21 ± 12.52
Week 24	2.82 ± 3.49	4.14 ± 3.80
Week 48	1.89 ± 2.30	3.38 ± 3.50
Hypertension	5 (14.7)	7 (21.9)
Type II diabetes	2 (5.8)	5 (15.6)*
Hyperlipidaemia	4 (11.8)	2 (6.2)

Data presented as mean ± SD or n of patients (%).

^*P < 0.05; last-observation-carried-forward analysis.